Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Chlorpheniramine mixture with hydrocodone, 131219-97-1, Vituz, Tuzistra xr, Tussionex pennkinetic, S-t forte 2
Molecular Formula
C34H40ClN3O3
Molecular Weight
574.1  g/mol
InChI Key
UUEZOEBHFHYMGR-RNWHKREASA-N

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
2.1.2 InChI
InChI=1S/C18H21NO3.C16H19ClN2/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19;1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3,6,11-12,17H,4-5,7-9H2,1-2H3;3-9,11,15H,10,12H2,1-2H3/t11-,12+,17-,18-;/m0./s1
2.1.3 InChI Key
UUEZOEBHFHYMGR-RNWHKREASA-N
2.1.4 Canonical SMILES
CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4.CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
2.1.5 Isomeric SMILES
CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4.CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Chlorpheniramine Mixture With Hydrocodone

2. 131219-97-1

3. Vituz

4. Tuzistra Xr

5. Tussionex Pennkinetic

6. S-t Forte 2

7. Tussicaps Extended-release

8. Tussionex

9. Chlorpheniramine / Hydrocodone

10. Chlorpheniramine Polistirex / Hydrocodone Polistirex

11. Chlorpheniramine Polistirex And Hydrocodone Polistirex

12. Hydrocodone Polistirex And Chlorpheniramine Polistirex

13. Schembl2522788

14. Dtxsid50156960

15. Hydrocodone Conbination Product 15 Mg/du

2.3 Create Date
2009-08-20
3 Chemical and Physical Properties
Molecular Weight 574.1 g/mol
Molecular Formula C34H40ClN3O3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass573.2758198 g/mol
Monoisotopic Mass573.2758198 g/mol
Topological Polar Surface Area54.9 Ų
Heavy Atom Count41
Formal Charge0
Complexity758
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameHydrocodone polistirex and chlorpheniramine polistirex
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormSuspension, extended release
RouteOral
Strengtheq 10mg bitartrate/5ml; eq 8mg maleate/5ml
Market StatusPrescription
CompanyTris Pharma

2 of 6  
Drug NameTussicaps
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormCapsule, extended release
RouteOral
Strengtheq 10mg bitartrate; eq 5mg bitartrate; eq 4mg maleate; eq 8mg maleate
Market StatusPrescription
CompanyEcr Pharma

3 of 6  
Drug NameTussionex pennkinetic
PubMed HealthHydrocodone and Chlorpheniramine Polistirex (Oral route)
Drug ClassesAntitussive, Opioid/Antihistamine Combination, Chlorpheniramine
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormSuspension, extended release
RouteOral
Strengtheq 10mg bitartrate/5ml; eq 8mg maleate/5ml
Market StatusPrescription
CompanyUcb

4 of 6  
Drug NameHydrocodone polistirex and chlorpheniramine polistirex
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormSuspension, extended release
RouteOral
Strengtheq 10mg bitartrate/5ml; eq 8mg maleate/5ml
Market StatusPrescription
CompanyTris Pharma

5 of 6  
Drug NameTussicaps
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormCapsule, extended release
RouteOral
Strengtheq 10mg bitartrate; eq 5mg bitartrate; eq 4mg maleate; eq 8mg maleate
Market StatusPrescription
CompanyEcr Pharma

6 of 6  
Drug NameTussionex pennkinetic
PubMed HealthHydrocodone and Chlorpheniramine Polistirex (Oral route)
Drug ClassesAntitussive, Opioid/Antihistamine Combination, Chlorpheniramine
Active IngredientChlorpheniramine polistirex; hydrocodone polistirex
Dosage FormSuspension, extended release
RouteOral
Strengtheq 10mg bitartrate/5ml; eq 8mg maleate/5ml
Market StatusPrescription
CompanyUcb

5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Histamine-1 Receptor Antagonist [EPC]; Opioid Agonist [EPC]; Opioid Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]